Furthermore, Brown and colleagues have demonstrated that MEKK2-deficient mice are resistant to the development of hypertension-induced ventricular hypertrophy [15], suggesting that MEKK2 may be an important factor in cardiac disease. This evidence concerns the gene MAP3K2 and cardiac hypertrophy.